Work

Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype

Year: 2013

Type: article

Study design: Clinical Trial

Source: Journal of Neuroimmunology

DOI: 10.1016/j.jneuroim.2013.08.011

Authors: Catherine Milch, Tim Wyant, Jing Xu, Asit Parikh, Whitney Kent, Irving Fox, Joseph Berger

Institutions: Takeda Oncology (United States), Takeda (United States), University of Kentucky

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Takeda Oncology, Takeda Pharmaceuticals International

OpenAlex ID: W2169051283

FWCI: 9.721

Cites: 14

Cited by: 78

Related to: 10